Avery Therapeutics is developing first-in-class immunomodulatory therapeutics to redirect the immune system to address diseases of aging, inflammation, and fibrosis. Avery's lead program is under development for heart failure, one of the leading causes of death in the world.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Tucson, Az 85719, Us
- in****@****era.com
- Industry
- Biotechnology
- Website
- averythera.com
- HQ
- Tucson, AZ
Avery Therapeutics, Inc. Questions
Avery Therapeutics, Inc.'s website is averythera.com
Avery Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/averythera
Avery Therapeutics, Inc. has
11 employees.
View email and phone details for 11
employees at Avery Therapeutics, Inc..
Avery Therapeutics, Inc.'s industry is
Biotechnology
Avery Therapeutics, Inc.'s top competitors are
Aimmune Therapeutics,
Kano Therapeutics,
Cytovia Therapeutics,
Fate Therapeutics Inc.,
Biomimetic Solutions,
Prelude Therapeutics,
Cellorigin Biotech,
Prellis Biologics,
Denali Therapeutics,
Shoreline Biosciences, Inc..
Avery Therapeutics, Inc.'s support email address is info@averythera.com
Avery Therapeutics, Inc.'s categories are Biotechnology
Avery Therapeutics, Inc.'s founding year is 2016
